查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1282920

原位杂交（ISH）市场-全球市场规模、份额、趋势分析、机会、预测报告，2019-2029，按技术；按探针；按产品；按应用；按最终用途

In Situ Hybridization Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Technology ; By Probe ; By Product ; By Application ; By End Use ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

原位杂交 (ISH) 全球市场规模到 2029 年将达到 32.6 亿美元

全球原位杂交 (ISH) 市场的推动因素包括人们对 ISH 使用意识的不断增强、医疗保健支出的增加、癌症患病率的增加以及对诊断癌症、染色体异常和传染病的需求不断增加。 ISH 在研究活动和实验室中的应用正在蓬勃发展。

领先的战略咨询和市场研究公司 BlueWeave Consulting 最近估计 2022 年全球原位杂交 (ISH) 市场规模为 14.2 亿美元。 BlueWeave 预测，2023-2029 年预测期内，全球原位杂交（ISH）市场规模将以 12.73% 的复合年增长率显着增长，到 2029 年将达到 32.6 亿美元的增长。 全球原位杂交（ISH）市场的一个关键增长动力是对分子诊断工具不断增长的需求。 ISH 的使用增加是由于慢性病发病率上升和对快速诊断方法的需求不断增长所致。 IVD领域的技术发展也是ISH市场的驱动因素之一。 高价值原位杂交（ISH）技术的发展以及原位杂交（ISH）在印度等新兴国家的日益普及将带来新的市场机遇。 然而，原位杂交（ISH）市场预计将受到探针成本高、FISH 检测患者显着异常的能力低以及检测过程冗长的阻碍。 高通量全基因组测序、微阵列等先进技术的可用性也制约着全球原位杂交（ISH）市场的发展。

全球原位杂交 (ISH) 市场 - 概述：

原位杂交 (ISH) 是一种用于检测细胞和组织中特定 DNA 或 RNA 序列的实验室技术。 该技术使用与目标 DNA 或 RNA 序列互补的标记核酸探针。 探针设计用于特异性结合靶序列，从而能够在所研究的细胞或组织内检测和定位它们。 原位杂交可用于研究多种生物现象，例如基因表达、基因突变、染色体畸变和病毒感染。 该技术广泛应用于癌症研究、发育生物学和神经科学等各个研究领域。

COVID-19 对全球原位杂交 (ISH) 市场的影响

COVID-19 大流行对原位杂交 (ISH) 市场产生了双重影响。 一方面，疫情对供应炼和製造流程的影响推迟了原位杂交（ISH）检测和试剂的製造和交付。 这影响了这些产品的可及性和可用性，特别是在受大流行影响的地区。 与此同时，疫情增加了 COVID-19 研究中对原位杂交 (ISH) 方法的需求。 利用原位杂交（ISH）可以在组织和细胞中检测到SARS-CoV-2病毒，并可以研究病毒的病理生理学和感染途径。 因此，人们越来越有兴趣使用原位杂交 (ISH) 作为 COVID-19 的研究和诊断工具。

全球原位杂交 (ISH) 市场 - 按产品：

按产品划分，全球原位杂交 (ISH) 市场分为仪器、试剂盒和探针、软件和服务。 到 2022 年，由于诊断实验室和实验室的需求不断增加，原位杂交 (ISH) 市场将由仪器领域主导，预计在预测期内其增长将持续。 对更好的显微镜和成像系统的需求预计将成为需求的主要驱动力，这些系统能够对 FISH、CISH 和 ISH 样品进行更高质量的成像。 研究人员和病理学家青睐这些仪器，因为它们具有成本效益、易用性和便携性等潜在优势。 另一方面，试剂盒和探针领域预计在预测期内将出现显着增长。 癌症等目标疾病发病率的增加预计将推动对这些产品的需求。 白血病、实体瘤、淋巴瘤和自闭症等遗传性疾病的增加预计将推动 FISH 和 CISH 探针的采用。 未来的市场增长预计将由医疗保健支出的增加、新型探针的研发力度的加大以及对高灵敏度、快速和准确的诊断技术的需求推动。

竞争格局：

全球原位杂交 (ISH) 市场的主要公司有：Thermo Fisher Scientific Inc.、Abbott (Abbott Molecular)、PerkinElmer Inc.、BioView、Agilent Technologies, Inc.、 Merck KGaA、Bio-Rad Laboratories, Inc、Oxford Gene Technology IP Limited、Leica Biosystems Nussloch GmbH、F. Hoffman-La Roche Limited、NeoGenomics Laboratories, Inc 和 Advanced Cell Diagnostics, Inc. 为了进一步增加其市场份额，这些公司正在采取各种策略，如併购、合作、合资、许可协议和新产品发布。

本报告的详细分析提供了有关全球原位杂交市场的增长潜力、未来趋势和统计数据的信息。 它还涵盖了推动市场总规模预测的因素。 该报告致力于提供全球原位杂交市场的最新技术趋势以及行业见解，使决策者能够做出明智的战略决策。 它还分析了市场的增长动力、挑战和竞争动态。

内容

第 1 章研究框架

第 2 章执行摘要

第 3 章全球原位杂交市场洞察

  • 行业价值链分析
  • DROC 分析
    • 增长动力
      • 目标疾病的患病率增加
      • 增加体外诊断的研发投入
    • 抑制因素
      • 存在不明确的监管框架
    • 机会
      • 人们对使用原位杂交的认识不断增强
    • 任务
      • 需要先进技术的劳动密集型产品
  • 技术进步/最新发展
  • 监管框架
  • 波特五力分析

第 4 章全球原位杂交市场概述

  • 2019-2029 年市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按技术
      • 萤光原位杂交 (FISH)
      • 显色原位杂交 (CISH)
    • 按探测
      • DNA RNA
    • 按产品
      • 工具
      • 试剂盒和探针
      • 软件
      • 服务
    • 按用途
      • 癌症
      • 细胞遗传学
      • 发育生物学
      • 感染
      • 其他
    • 按最终用途
      • 研究和诊断实验室
      • 合同研究组织
      • 学术机构
      • 其他
    • 按地区
      • 北美
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲 (MEA)

第 5 章北美原位杂交市场

  • 2019-2029 年市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按技术
    • 按探测
    • 按产品
    • 按用途
    • 按最终用途
    • 按国家/地区
      • 美国
      • 加拿大

第 6 章欧洲原位杂交市场

  • 2019-2029 年市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按技术
    • 按探测
    • 按产品
    • 按用途
    • 按最终用途
    • 按国家/地区
      • 德国
      • 英国
      • 意大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 欧洲其他地区

第 7 章亚太原位杂交市场

  • 2019-2029 年市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按技术
    • 按探测
    • 按产品
    • 按用途
    • 按最终用途
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳大利亚和新西兰
      • 印度尼西亚
      • 马来西亚
      • 新加坡
      • 越南
      • 亚太地区的其他国家/地区

第 8 章拉丁美洲原位杂交市场

  • 2019-2029 年市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按技术
    • 按探测
    • 按产品
    • 按用途
    • 按最终用途
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 其余拉丁美洲地区

第 9 章中东和非洲原位杂交市场

  • 2019-2029 年市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按技术
    • 按探测
    • 按产品
    • 按用途
    • 按最终用途
    • 按国家/地区
      • 沙特阿拉伯
      • 阿拉伯联合酋长国
      • 卡塔尔
      • 科威特
      • 南非
      • 尼日利亚
      • 阿尔及利亚
      • 多边环境协定的其余部分

第 10 章竞争格局

  • 主要公司及其产品列表
  • 2022年全球原位杂交企业市场份额分析
  • 通过运行参数进行竞争基准测试
  • 重大战略发展（合併、收购、合作伙伴关係等）

第 11 章 COVID-19 对全球原位杂交市场的影响

第 12 章公司简介（公司简介、财务矩阵、竞争格局、关键人才、主要竞争对手、联繫地址、战略展望、SWOT 分析）

  • Thermo Fisher Scientific Inc.
  • Abbott（Abbott Molecular）
  • PerkinElmer, Inc.
  • BioView
  • Agilent Technologies, Inc.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Oxford Gene Technology IP Limited
  • Leica Biosystems Nussloch GmbH
  • F. Hoffman-La Roche Limited
  • NeoGenomics Laboratories, Inc.
  • Advanced Cell Diagnostics, Inc.
  • Other Prominent Players

第 13 章关键战略建议

第 14 章研究方法

  • 定性研究
    • 初级和次级研究
  • 定量研究
  • 市场细分和数据三角测量
    • 二次调查
    • 初步调查
  • 主要调查受访者按地区细分
  • 假设和限制
简介目录
Product Code: BWC23423

Global In Situ Hybridization (ISH) Market Size Set to Touch USD 3.26 billion by 2029

Global in situ hybridization (ISH) market is flourishing because of rising awareness of the use of ISH, increasing levels of healthcare expenditures, growing cancer prevalence, and high adoption of ISH in research activities and laboratories to diagnose cancer, chromosomal abnormalities, and infectious diseases.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global in situ hybridization (ISH) market size at USD 1.42 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global in situ hybridization market size to grow at a significant CAGR of 12.73% reaching a value of USD 3.26 billion by 2029. Major growth drivers for the global in situ hybridization market include the rising need for molecular diagnostic tools. The expanding use of ISH is a result of both the rising incidence of chronic diseases and the growing demand for quick diagnostic methods. Technology developments in the IVD (in vitro diagnostics) sector are the other drivers of the ISH market. The development of high value in situ hybridization technologies and the expansion of in situ hybridization use in developing countries like India will provide new market opportunities. However, the in situ hybridization market is anticipated to be hampered by the high cost of probes, FISH's poor ability to detect significant patient abnormalities, and the lengthy detection processes. Also, the development of the global In Situ Hybridization (ISH) market is constrained by the availability of superior technologies, including high-throughput whole genome sequencing, microarray, and others.

Global In situ Hybridization Market - Overview:

In situ hybridization (ISH) is a laboratory technique used to detect specific DNA or RNA sequences in cells or tissues. The technique involves the use of a labelled nucleic acid probe that is complementary to the target DNA or RNA sequence. The probe is designed to bind specifically to the target sequence, allowing for its detection and localization within the cells or tissues under study. In situ hybridization can be used to study a wide range of biological phenomena, including gene expression, genetic mutations, chromosomal abnormalities, and viral infections. The technique is widely used in various fields of research, including cancer research, developmental biology, and neuroscience, among others.

Impact of COVID-19 on Global In situ Hybridization Market

COVID-19 pandemic had a dual impact on the market for in situ hybridization. On the one hand, the manufacturing and delivery of in situ hybridization assays and reagents were delayed due to the pandemic's impact on supply chains and manufacturing processes. This had an influence on the accessibility and availability of these products, especially in areas where the pandemic has had a significant impact. On the other hand, the pandemic enhanced the need for in situ hybridization methods in COVID-19 research. The SARS-CoV-2 virus may be found in tissues and cells using in situ hybridization, which can also be used to examine the pathophysiology and transmission of the virus. Consequently, there was an increasing interest in using in situ hybridization as a COVID-19 research and diagnostic tool.

Global In situ Hybridization Market - By Product:

Based on product, the global in situ hybridization market is segmented into Instruments, Kits & Probes, Software, and Services segments. In 2022, the instruments segment dominated the in situ Hybridization (ISH) market, and its growth is expected to continue during the forecast period due to the increasing demand from diagnostic and research laboratories. The need for better microscopes and imaging systems to enable higher quality imaging of FISH, CISH, and ISH samples is predicted to be a major driver of demand. Researchers and pathologists favor these instruments due to their potential benefits, such as greater cost-effectiveness, ease of use, and portability. Meanwhile, the kits and probes segment is expected to witness significant growth during the forecast period. The increasing incidence of target disorders like cancer is anticipated to drive demand for these products. The rise in genetic diseases such as leukemia, solid tumors, lymphoma, and autism is expected to boost the adoption of FISH and CISH probes. The market's future growth is projected to be driven by a rise in healthcare expenditure, an increase in R&D for the development of novel probes, and the demand for sensitive, rapid, and accurate diagnostic techniques.

Competitive Landscape:

Major players operating in the global in situ hybridization market include: Thermo Fisher Scientific Inc., Abbott (Abbott Molecular), PerkinElmer Inc., BioView, Agilent Technologies, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Oxford Gene Technology IP Limited, Leica Biosystems Nussloch GmbH, F. Hoffman-La Roche Limited, NeoGenomics Laboratories, Inc., and Advanced Cell Diagnostics, Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The report's in-depth analysis provides information about growth potential, upcoming trends, and the Global In Situ Hybridization Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global In Situ Hybridization Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global In-Situ Hybridization Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Growing Prevalence of Target Disorders
      • 3.2.1.2. Rising R&D Investments in In-Vitro Diagnostics
    • 3.2.2. Restraints
      • 3.2.2.1. Presence of an Ambiguous Regulatory Framework
    • 3.2.3. Opportunities
      • 3.2.3.1. Growing Awareness About the In-Situ Hybridization Usage
    • 3.2.4. Challenges
      • 3.2.4.1. Highly Skilled Labor-Intensive Product
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global In-Situ Hybridization Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Technology
      • 4.2.1.1. Fluorescent In-Situ Hybridization (FISH)
      • 4.2.1.2. Chromogenic In-Situ Hybridization (CISH)
    • 4.2.2. By Probe
      • 4.2.2.1. DNA
      • 4.2.2.2. RNA
    • 4.2.3. By Product
      • 4.2.3.1. Instruments
      • 4.2.3.2. Kits & Probes
      • 4.2.3.3. Software
      • 4.2.3.4. Services
    • 4.2.4. By Application
      • 4.2.4.1. Cancer
      • 4.2.4.2. Cytogenetics
      • 4.2.4.3. Developmental Biology
      • 4.2.4.4. Infectious Diseases
      • 4.2.4.5. Others
    • 4.2.5. By End Use
      • 4.2.5.1. Research & Diagnostic Laboratories
      • 4.2.5.2. CROs
      • 4.2.5.3. Academic Institutes
      • 4.2.5.4. Others
    • 4.2.6. By Region
      • 4.2.6.1. North America
      • 4.2.6.2. Europe
      • 4.2.6.3. Asia Pacific (APAC)
      • 4.2.6.4. Latin America (LATAM)
      • 4.2.6.5. Middle East and Africa (MEA)

5. North America In-Situ Hybridization Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology
    • 5.2.2. By Probe
    • 5.2.3. By Product
    • 5.2.4. By Application
    • 5.2.5. By End Use
    • 5.2.6. By Country
      • 5.2.6.1. United States
      • 5.2.6.1.1. By Technology
      • 5.2.6.1.2. By Probe
      • 5.2.6.1.3. By Product
      • 5.2.6.1.4. By Application
      • 5.2.6.1.5. By End Use
      • 5.2.6.2. Canada
      • 5.2.6.2.1. By Technology
      • 5.2.6.2.2. By Probe
      • 5.2.6.2.3. By Product
      • 5.2.6.2.4. By Application
      • 5.2.6.2.5. By End Use

6. Europe In-Situ Hybridization Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Probe
    • 6.2.3. By Product
    • 6.2.4. By Application
    • 6.2.5. By End Use
    • 6.2.6. By Country
      • 6.2.6.1. Germany
      • 6.2.6.1.1. By Technology
      • 6.2.6.1.2. By Probe
      • 6.2.6.1.3. By Product
      • 6.2.6.1.4. By Application
      • 6.2.6.1.5. By End Use
      • 6.2.6.2. United Kingdom
      • 6.2.6.2.1. By Technology
      • 6.2.6.2.2. By Probe
      • 6.2.6.2.3. By Product
      • 6.2.6.2.4. By Application
      • 6.2.6.2.5. By End Use
      • 6.2.6.3. Italy
      • 6.2.6.3.1. By Technology
      • 6.2.6.3.2. By Probe
      • 6.2.6.3.3. By Product
      • 6.2.6.3.4. By Application
      • 6.2.6.3.5. By End Use
      • 6.2.6.4. France
      • 6.2.6.4.1. By Technology
      • 6.2.6.4.2. By Probe
      • 6.2.6.4.3. By Product
      • 6.2.6.4.4. By Application
      • 6.2.6.4.5. By End Use
      • 6.2.6.5. Spain
      • 6.2.6.5.1. By Technology
      • 6.2.6.5.2. By Probe
      • 6.2.6.5.3. By Product
      • 6.2.6.5.4. By Application
      • 6.2.6.5.5. By End Use
      • 6.2.6.6. Belgium
      • 6.2.6.6.1. By Technology
      • 6.2.6.6.2. By Probe
      • 6.2.6.6.3. By Product
      • 6.2.6.6.4. By Application
      • 6.2.6.6.5. By End Use
      • 6.2.6.7. Russia
      • 6.2.6.7.1. By Technology
      • 6.2.6.7.2. By Probe
      • 6.2.6.7.3. By Product
      • 6.2.6.7.4. By Application
      • 6.2.6.7.5. By End Use
      • 6.2.6.8. The Netherlands
      • 6.2.6.8.1. By Technology
      • 6.2.6.8.2. By Probe
      • 6.2.6.8.3. By Product
      • 6.2.6.8.4. By Application
      • 6.2.6.8.5. By End Use
      • 6.2.6.9. Rest of Europe
      • 6.2.6.9.1. By Technology
      • 6.2.6.9.2. By Probe
      • 6.2.6.9.3. By Product
      • 6.2.6.9.4. By Application
      • 6.2.6.9.5. By End Use

7. Asia-Pacific In-Situ Hybridization Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Probe
    • 7.2.3. By Product
    • 7.2.4. By Application
    • 7.2.5. By End Use
    • 7.2.6. By Country
      • 7.2.6.1. China
      • 7.2.6.1.1. By Technology
      • 7.2.6.1.2. By Probe
      • 7.2.6.1.3. By Product
      • 7.2.6.1.4. By Application
      • 7.2.6.1.5. By End Use
      • 7.2.6.2. India
      • 7.2.6.2.1. By Technology
      • 7.2.6.2.2. By Probe
      • 7.2.6.2.3. By Product
      • 7.2.6.2.4. By Application
      • 7.2.6.2.5. By End Use
      • 7.2.6.3. Japan
      • 7.2.6.3.1. By Technology
      • 7.2.6.3.2. By Probe
      • 7.2.6.3.3. By Product
      • 7.2.6.3.4. By Application
      • 7.2.6.3.5. By End Use
      • 7.2.6.4. South Korea
      • 7.2.6.4.1. By Technology
      • 7.2.6.4.2. By Probe
      • 7.2.6.4.3. By Product
      • 7.2.6.4.4. By Application
      • 7.2.6.4.5. By End Use
      • 7.2.6.5. Australia & New Zealand
      • 7.2.6.5.1. By Technology
      • 7.2.6.5.2. By Probe
      • 7.2.6.5.3. By Product
      • 7.2.6.5.4. By Application
      • 7.2.6.5.5. By End Use
      • 7.2.6.6. Indonesia
      • 7.2.6.6.1. By Technology
      • 7.2.6.6.2. By Probe
      • 7.2.6.6.3. By Product
      • 7.2.6.6.4. By Application
      • 7.2.6.6.5. By End Use
      • 7.2.6.7. Malaysia
      • 7.2.6.7.1. By Technology
      • 7.2.6.7.2. By Probe
      • 7.2.6.7.3. By Product
      • 7.2.6.7.4. By Application
      • 7.2.6.7.5. By End Use
      • 7.2.6.8. Singapore
      • 7.2.6.8.1. By Technology
      • 7.2.6.8.2. By Probe
      • 7.2.6.8.3. By Product
      • 7.2.6.8.4. By Application
      • 7.2.6.8.5. By End Use
      • 7.2.6.9. Vietnam
      • 7.2.6.9.1. By Technology
      • 7.2.6.9.2. By Probe
      • 7.2.6.9.3. By Product
      • 7.2.6.9.4. By Application
      • 7.2.6.9.5. By End Use
      • 7.2.6.10. Rest of APAC
      • 7.2.6.10.1. By Technology
      • 7.2.6.10.2. By Probe
      • 7.2.6.10.3. By Product
      • 7.2.6.10.4. By Application
      • 7.2.6.10.5. By End Use

8. Latin America In-Situ Hybridization Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Probe
    • 8.2.3. By Product
    • 8.2.4. By Application
    • 8.2.5. By End Use
    • 8.2.6. By Country
      • 8.2.6.1. Brazil
      • 8.2.6.1.1. By Technology
      • 8.2.6.1.2. By Probe
      • 8.2.6.1.3. By Product
      • 8.2.6.1.4. By Application
      • 8.2.6.1.5. By End Use
      • 8.2.6.2. Mexico
      • 8.2.6.2.1. By Technology
      • 8.2.6.2.2. By Probe
      • 8.2.6.2.3. By Product
      • 8.2.6.2.4. By Application
      • 8.2.6.2.5. By End Use
      • 8.2.6.3. Argentina
      • 8.2.6.3.1. By Technology
      • 8.2.6.3.2. By Probe
      • 8.2.6.3.3. By Product
      • 8.2.6.3.4. By Application
      • 8.2.6.3.5. By End Use
      • 8.2.6.4. Peru
      • 8.2.6.4.1. By Technology
      • 8.2.6.4.2. By Probe
      • 8.2.6.4.3. By Product
      • 8.2.6.4.4. By Application
      • 8.2.6.4.5. By End Use
      • 8.2.6.5. Rest of LATAM
      • 8.2.6.5.1. By Technology
      • 8.2.6.5.2. By Probe
      • 8.2.6.5.3. By Product
      • 8.2.6.5.4. By Application
      • 8.2.6.5.5. By End Use

9. Middle East & Africa In-Situ Hybridization Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Probe
    • 9.2.3. By Product
    • 9.2.4. By Application
    • 9.2.5. By End Use
    • 9.2.6. By Country
      • 9.2.6.1. Saudi Arabia
      • 9.2.6.1.1. By Technology
      • 9.2.6.1.2. By Probe
      • 9.2.6.1.3. By Product
      • 9.2.6.1.4. By Application
      • 9.2.6.1.5. By End Use
      • 9.2.6.2. UAE
      • 9.2.6.2.1. By Technology
      • 9.2.6.2.2. By Probe
      • 9.2.6.2.3. By Product
      • 9.2.6.2.4. By Application
      • 9.2.6.2.5. By End Use
      • 9.2.6.3. Qatar
      • 9.2.6.3.1. By Technology
      • 9.2.6.3.2. By Probe
      • 9.2.6.3.3. By Product
      • 9.2.6.3.4. By Application
      • 9.2.6.3.5. By End Use
      • 9.2.6.4. Kuwait
      • 9.2.6.4.1. By Technology
      • 9.2.6.4.2. By Probe
      • 9.2.6.4.3. By Product
      • 9.2.6.4.4. By Application
      • 9.2.6.4.5. By End Use
      • 9.2.6.5. South Africa
      • 9.2.6.5.1. By Technology
      • 9.2.6.5.2. By Probe
      • 9.2.6.5.3. By Product
      • 9.2.6.5.4. By Application
      • 9.2.6.5.5. By End Use
      • 9.2.6.6. Nigeria
      • 9.2.6.6.1. By Technology
      • 9.2.6.6.2. By Probe
      • 9.2.6.6.3. By Product
      • 9.2.6.6.4. By Application
      • 9.2.6.6.5. By End Use
      • 9.2.6.7. Algeria
      • 9.2.6.7.1. By Technology
      • 9.2.6.7.2. By Probe
      • 9.2.6.7.3. By Product
      • 9.2.6.7.4. By Application
      • 9.2.6.7.5. By End Use
      • 9.2.6.8. Rest of MEA
      • 9.2.6.8.1. By Technology
      • 9.2.6.8.2. By Probe
      • 9.2.6.8.3. By Product
      • 9.2.6.8.4. By Application
      • 9.2.6.8.5. By End Use

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global In-Situ Hybridization Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global In-Situ Hybridization Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Thermo Fisher Scientific Inc.
  • 12.2. Abbott (Abbott Molecular)
  • 12.3. PerkinElmer, Inc.
  • 12.4. BioView
  • 12.5. Agilent Technologies, Inc.
  • 12.6. Merck KGaA
  • 12.7. Bio-Rad Laboratories, Inc.
  • 12.8. Oxford Gene Technology IP Limited
  • 12.9. Leica Biosystems Nussloch GmbH
  • 12.10. F. Hoffman-La Roche Limited
  • 12.11. NeoGenomics Laboratories, Inc.
  • 12.12. Advanced Cell Diagnostics, Inc.
  • 12.13. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations